MedPath

Music for Sleep-onset Insomnia

Not Applicable
Completed
Conditions
Insomnia
Interventions
Behavioral: Sleep hygiene advice
Behavioral: Bedtime music listening
Registration Number
NCT04585425
Lead Sponsor
University of Aarhus
Brief Summary

The study is a randomized controlled trial evaluating the effect of bedtime music as an early intervention for sleep-onset insomnia in adults. The investigators use a randomized controlled trial design with two parallel groups. All participants receive sleep hygiene advice as standard treatment and participants in the intervention group are additionally asked to listen to a sleep playlist daily at bedtime. Subjective and objective sleep measures are evaluated before and after the 4 weeks intervention period. In addition, follow-up measures of subjective outcomes are assessed 4 weeks after the end of the intervention period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Sleep-onset insomnia for 3-18 months
Read More
Exclusion Criteria
  1. use of medications (benzodiazepines, z-drugs, antidepressive and anti-psychotic drugs)
  2. alcohol or substance abuse
  3. pregnant or breastfeeding women
  4. other sleep disorders (e.g. sleep apnea, restless leg syndrome, etc.)
  5. current psychiatric disorder or a history of psychotic disorders
  6. somatic disorders interfering with sleep (e.g. critical illness, pain disorders, neuro-degenerative disorders)
  7. shift work.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionBedtime music listeningTreatment as usual (sleep hygiene advice) and bedtime music listening
ControlSleep hygiene adviceTreatment as usual including sleep hygiene advice
InterventionSleep hygiene adviceTreatment as usual (sleep hygiene advice) and bedtime music listening
Primary Outcome Measures
NameTimeMethod
Insomnia severityChange from baseline to after the 4-week intervention period.

Measured with the Insomnia Severity Index, range 0-28 with higher scores indicating more severe insomnia.

Secondary Outcome Measures
NameTimeMethod
Sleep-wake patternChange from baseline to after the 4-week intervention period.

Sleep-wake pattern as measured with wrist-actigraphy

Objective sleep qualityChange from baseline to after the 4-week intervention period.

Objective sleep quality as measured with polysomnography

Sleep qualityChange from baseline to after the 4-week intervention period.

Measured with the Pittsburgh Sleep Quality Index, range 0-21 with higher scores indicating more sleep problems.

Quality of lifeChange from baseline to after the 4-week intervention period.

Quality of life as measured with SF-36, range 0-100 with higher scores indicating better quality of life.

Sleep initiation difficultiesChange from baseline to after the 4-week intervention period.

Difficulties initiating sleep as measured with Pittsburgh Sleep Quality Index subscale

Pre-sleep arousalChange from baseline to after the 4-week intervention period.

Pre-sleep arousal as measured with the Pre-Sleep Arousal Scale, range 8-40 with higher scores indicating higher pre-sleep arousal.

Trial Locations

Locations (1)

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath